haloperidol has been researched along with Aging in 127 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Practice guidelines recommend the use of low dose haloperidol when medication is needed to treat delirium with acute agitation in hospitalized older people." | 7.79 | Haloperidol overdosing in the treatment of agitated hospitalized older people with delirium: a retrospective chart review from a community teaching hospital. ( Dorokhine, I; Knapp, CM; Musuku, M; Patel, N; Zirker, W, 2013) |
| "The aim of the study was to examine the influence of hyperprolactinemia, induced by haloperidol (HAL) on age related morphology and function changes of epithelial cells in rat prostate lateral lobe." | 7.72 | Aging process of epithelial cells of the rat prostate lateral lobe in experimental hyperprolactinemia induced by haloperidol. ( Laszczyńska, M; Piasecka, M; Słuczanowska-Glabowska, S; Wylot, M, 2004) |
| "In haloperidol-induced catalepsy in rats (1." | 5.30 | Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders. ( Cohen, S; Levy, R; Speiser, Z, 1998) |
| "Haloperidol treatment (2 hours) accelerated striatal DA turnover similarly in all age groups, by about 100%." | 5.26 | Aging and haloperidol-induced dopamine turnover in the nigro-striatal pathway of C57BL/6J mice. ( Finch, CE; Osterburg, HH; Severson, JA, 1981) |
| " Recent studies suggest that aging may be associated with epigenetic changes and that valproic acid (VPA), a histone deacetylase inhibitor, may reverse such changes." | 3.80 | HDAC inhibitors restore the capacity of aged mice to respond to haloperidol through modulation of histone acetylation. ( Csernansky, JG; Dong, H; Fang, D; Gallardo, C; Gerst, N; Keegan, J; Matsumoto, M; Montalvo-Ortiz, JL; Tetsuka, K; Tucker, C, 2014) |
| "Practice guidelines recommend the use of low dose haloperidol when medication is needed to treat delirium with acute agitation in hospitalized older people." | 3.79 | Haloperidol overdosing in the treatment of agitated hospitalized older people with delirium: a retrospective chart review from a community teaching hospital. ( Dorokhine, I; Knapp, CM; Musuku, M; Patel, N; Zirker, W, 2013) |
| "The aim of the study was to examine the influence of hyperprolactinemia, induced by haloperidol (HAL) on age related morphology and function changes of epithelial cells in rat prostate lateral lobe." | 3.72 | Aging process of epithelial cells of the rat prostate lateral lobe in experimental hyperprolactinemia induced by haloperidol. ( Laszczyńska, M; Piasecka, M; Słuczanowska-Glabowska, S; Wylot, M, 2004) |
| "Olanzapine treated subjects showed reduced day 4 deficit (compared with day 1), with no significant difference from placebo beyond 6 h post dose." | 2.69 | A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers. ( Beuzen, JN; Taylor, N; Wesnes, K; Wood, A, 1999) |
| "These results suggest that epigenetic changes at the striatal Drd2 promoter drive age-related increases in antipsychotic side effect susceptibility, and HDAC inhibitors may be an effective adjunct treatment strategy to reduce side effects in aged populations." | 1.46 | Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice. ( Csernansky, JG; Dong, H; Fang, D; Fisher, DW; Montalvo-Ortiz, JL; Rodríguez, G, 2017) |
| "Animal work on the behavioral effects of antipsychotic treatment suggests that different dosing regimens could affect drug sensitivity differently, with an intermittent treatment regimen tending to cause a sensitization effect, while a continuous treatment causing a tolerance." | 1.40 | Differential effects of intermittent versus continuous haloperidol treatment throughout adolescence on haloperidol sensitization and social behavior in adulthood. ( Gao, J; Li, M, 2014) |
| "Catalepsy was measured using the bar test." | 1.39 | Somatostatin antagonist induces catalepsy in the aged rat. ( Ionov, ID; Pushinskaya, II, 2013) |
| "In rodents and dog, histamine induces catalepsy, a dopamine-dependent phenomenon that resembles the extrapyramidal signs of Parkinson's disease (PD)." | 1.38 | Histamine- and haloperidol-induced catalepsy in aged mice: differential responsiveness to L-DOPA. ( Ionov, ID; Severtsev, NN, 2012) |
| "Catalepsy was measured using the bar test." | 1.38 | Somatostatin antagonist potentiates haloperidol-induced catalepsy in the aged rat. ( Ionov, ID; Severtsev, NN, 2012) |
| "Both haloperidol and clozapine produced catalepsy and haloperidol decreased locomotion in shipped and bred rats of both sexes, with sensitization to haloperidol-induced catalepsy developing with repeated dosing." | 1.35 | To breed or not to breed? Empirical evaluation of drug effects in adolescent rats. ( Evans, RL; Wiley, JL, 2009) |
| " Subsequently, in order to determine whether tolerance to the activity suppressive effects of these drugs would occur in adolescents, PN40 rats were dosed and assessed for an additional nine days." | 1.35 | Antipsychotic-induced suppression of locomotion in juvenile, adolescent and adult rats. ( Wiley, JL, 2008) |
| "Haloperidol did not increase NT/NN mRNA expression in the nucleus accumbens until postnatal day 15 and did not increase NT concentrations in this brain region until postnatal day 21." | 1.31 | The effects of acute antipsychotic drug administration on the neurotensin system of the developing rat brain. ( Kinkead, B; Nemeroff, CB; Owens, MJ, 2000) |
| "In haloperidol-induced catalepsy in rats (1." | 1.30 | Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders. ( Cohen, S; Levy, R; Speiser, Z, 1998) |
| " Eighteen-day-old rats were 35% and 63% more sensitive than adults to the effects of haloperidol on striatal and accumbens turnover and had steeper dose-response curves." | 1.29 | Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol. ( Baldessarini, RJ; Barber, NI; Campbell, A; Gallitano, AL; Gelbard, HA; Marsh, E; Teicher, MH, 1993) |
| " Animals that were lesioned and treated with haloperidol chronically had longer durations of catalepsy at the first two dose-response determinations." | 1.29 | Partial 6-hydroxydopamine-induced lesions and haloperidol-induced catalepsy. ( Fisher, H; Johnson, SK; Wagner, GC, 1993) |
| "Catalepsy was measured by the bar test." | 1.28 | Effects of age and isolation on the evolution of catalepsy during chronic haloperidol treatment. ( Frussa-Filho, R; Otoboni, JR; Palermo-Neto, J; Uema, FT, 1992) |
| "In haloperidol-treated rats, unlike naive animals, activation of neostriatal D2 dopamine receptors induced a potent presynaptic inhibition of glutamate-mediated excitatory synaptic potentials." | 1.28 | Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission. ( Bernardi, G; Calabresi, P; De Murtas, M; Mercuri, NB, 1992) |
| "When naloxone was added to apomorphine there was a peculiar effect: the duration of the immobility reflex was increased significantly in rats of 20 days and adults, but not in 10-day-old rats." | 1.28 | Ontogeny of the endorphinergic and dopaminergic modulation on the immobility reflex elicited by clamping in rats. ( de la Cruz, F; Junquera, J; Russek, M, 1990) |
| "Haloperidol blood levels were not correlated with the age of the patient." | 1.27 | Blood levels of haloperidol in schizophrenic patients. ( Dekirmenjian, H; Shvartsburd, A; Smith, RC, 1983) |
| "Similarly, catalepsy induced by (-)-sulpiride (40 mg/kg, i." | 1.27 | Influence of (-)-sulpiride and YM-09151-2 on stereotyped behavior in chicks and catalepsy in rats. ( Wambebe, C, 1987) |
| " Dose-response studies of catalepsy and ptosis were conducted in male Sprague-Dawley rats aged 30, 56, or 100 days." | 1.27 | Decreasing sensitivity to neuroleptic agents in developing rats; evidence for a pharmacodynamic factor. ( Baldessarini, RJ; Campbell, A; Teicher, MH, 1988) |
| "carbachol) were applied, but did not appear until 18 months when partial agonists (e." | 1.27 | Age-related decrements in the muscarinic enhancement of K+-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence. ( Dalton, TK; Hunt, WA; Joseph, JA, 1988) |
| "The behavioral effect (catalepsy) of HAL was less in old than in young rats." | 1.27 | Reduced metabolic response of the aged rat brain to haloperidol. ( Holloway, HW; Pizzolato, G; Rapoport, SI; Soncrant, TT, 1985) |
| "Haloperidol was administered i." | 1.26 | Age effects on haloperidol pharmacokinetics in male, Fischer-344 rats. ( Kapetanovic, IM; Rapoport, SI; Sweeney, DJ, 1982) |
| "Haloperidol treatment (2 hours) accelerated striatal DA turnover similarly in all age groups, by about 100%." | 1.26 | Aging and haloperidol-induced dopamine turnover in the nigro-striatal pathway of C57BL/6J mice. ( Finch, CE; Osterburg, HH; Severson, JA, 1981) |
| "It is proposed that the decrement in catalepsy occurring between 10 and 15 days of age is related to increased dopaminergic activity in the neostriatum." | 1.26 | Dopaminergic antagonism and catalepsy in the developing rat. ( Baez, LA; Burt, DK; Granneman, J; Shanklin, C, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 59 (46.46) | 18.7374 |
| 1990's | 38 (29.92) | 18.2507 |
| 2000's | 16 (12.60) | 29.6817 |
| 2010's | 11 (8.66) | 24.3611 |
| 2020's | 3 (2.36) | 2.80 |
| Authors | Studies |
|---|---|
| Szocsics, P | 1 |
| Papp, P | 1 |
| Havas, L | 1 |
| Lőke, J | 1 |
| Maglóczky, Z | 1 |
| Huang, H | 1 |
| Zhang, B | 1 |
| Zheng, S | 1 |
| Li, C | 1 |
| Zhu, X | 1 |
| Wang, J | 1 |
| Montalvo-Ortiz, JL | 2 |
| Fisher, DW | 1 |
| Rodríguez, G | 1 |
| Fang, D | 2 |
| Csernansky, JG | 2 |
| Dong, H | 2 |
| McDougall, SA | 2 |
| Mohd-Yusof, A | 1 |
| Kaplan, GJ | 1 |
| Abdulla, ZI | 1 |
| Lee, RJ | 1 |
| Crawford, CA | 2 |
| Zirker, W | 1 |
| Dorokhine, I | 1 |
| Knapp, CM | 1 |
| Patel, N | 1 |
| Musuku, M | 1 |
| Labouesse, MA | 1 |
| Stadlbauer, U | 1 |
| Langhans, W | 1 |
| Meyer, U | 1 |
| Keegan, J | 1 |
| Gallardo, C | 1 |
| Gerst, N | 1 |
| Tetsuka, K | 1 |
| Tucker, C | 1 |
| Matsumoto, M | 1 |
| Gao, J | 1 |
| Li, M | 1 |
| Wiley, JL | 3 |
| Kendler, SH | 1 |
| Burston, JJ | 1 |
| Howard, DR | 1 |
| Selley, DE | 1 |
| Sim-Selley, LJ | 1 |
| Black, MD | 1 |
| Varty, GB | 1 |
| Arad, M | 1 |
| Barak, S | 1 |
| De Levie, A | 1 |
| Boulay, D | 1 |
| Pichat, P | 1 |
| Griebel, G | 1 |
| Weiner, I | 3 |
| Evans, RL | 1 |
| Wegener, N | 1 |
| Koch, M | 1 |
| Toua, C | 1 |
| Brand, L | 1 |
| Möller, M | 1 |
| Emsley, RA | 1 |
| Harvey, BH | 2 |
| Der-Ghazarian, T | 1 |
| Charntikov, S | 1 |
| Varela, FA | 1 |
| Ionov, ID | 3 |
| Severtsev, NN | 2 |
| Pushinskaya, II | 1 |
| Zuckerman, L | 1 |
| Rehavi, M | 1 |
| Nachman, R | 1 |
| Nel, A | 1 |
| Ohara, K | 1 |
| Shibuya, H | 1 |
| Andreassen, OA | 1 |
| Ferrante, RJ | 1 |
| Aamo, TO | 1 |
| Beal, MF | 1 |
| Jørgensen, HA | 1 |
| Wylot, M | 1 |
| Laszczyńska, M | 1 |
| Słuczanowska-Glabowska, S | 1 |
| Piasecka, M | 1 |
| Burchinsky, SG | 1 |
| Petkov, VV | 2 |
| Petkov, VD | 2 |
| Grahovska, T | 1 |
| Konstantinova, E | 2 |
| Rivera-Calimlim, L | 1 |
| Hershey, L | 1 |
| Marquis, JK | 1 |
| Lippa, AS | 1 |
| Pelham, RW | 1 |
| Lorden, JF | 2 |
| McKeon, TW | 2 |
| Baker, HJ | 1 |
| Cox, N | 1 |
| Walkley, SU | 2 |
| Oltmans, GA | 1 |
| Beales, M | 1 |
| Joseph, JA | 3 |
| Bartus, RT | 1 |
| Clody, D | 1 |
| Morgan, D | 1 |
| Finch, C | 1 |
| Beer, B | 1 |
| Sesack, S | 1 |
| Hill, HF | 1 |
| Engblom, J | 1 |
| Meyer, ME | 1 |
| Smith, RL | 1 |
| Van Hartesveldt, C | 1 |
| Shapiro, AK | 1 |
| Shapiro, E | 1 |
| Sowers, JR | 1 |
| Resch, G | 1 |
| Walker, S | 1 |
| Sollars, E | 1 |
| Campbell, A | 3 |
| Baldessarini, RJ | 3 |
| Shvartsburd, A | 1 |
| Dekirmenjian, H | 1 |
| Smith, RC | 1 |
| Kapetanovic, IM | 1 |
| Sweeney, DJ | 1 |
| Rapoport, SI | 2 |
| Kohno, Y | 1 |
| Tanaka, M | 1 |
| Nakagawa, R | 1 |
| Ida, Y | 1 |
| Iimori, K | 1 |
| Nagasaki, N | 1 |
| Dugas, M | 2 |
| Zarifian, E | 2 |
| Le Heuzey, MF | 2 |
| Regnier, N | 1 |
| Durand, G | 2 |
| Bianchetti, G | 2 |
| Morselli, PL | 2 |
| Algeri, S | 1 |
| Achilli, G | 1 |
| Cimino, M | 1 |
| Perego, C | 1 |
| Ponzio, F | 1 |
| Vantini, G | 1 |
| Roffman, M | 1 |
| Cordasco, F | 1 |
| Kling, A | 1 |
| Randall, PK | 1 |
| Severson, JA | 2 |
| Finch, CE | 2 |
| Rowell, FJ | 1 |
| Hui, SM | 1 |
| Fairbairn, AF | 1 |
| Eccleston, D | 1 |
| Osterburg, HH | 1 |
| Marwaha, J | 1 |
| Hoffer, B | 1 |
| Pittman, R | 1 |
| Freedman, R | 1 |
| Memo, M | 1 |
| Lucchi, L | 1 |
| Spano, PF | 2 |
| Trabucchi, M | 2 |
| Bowyer, JF | 1 |
| Henderson, MG | 1 |
| McMillen, BA | 1 |
| Lin, MY | 1 |
| Walters, DE | 2 |
| De Vries, TJ | 1 |
| Jonker, AJ | 1 |
| Voorn, P | 1 |
| Mulder, AH | 1 |
| Schoffelmeer, AN | 1 |
| Soghomonian, JJ | 1 |
| Teicher, MH | 2 |
| Barber, NI | 1 |
| Gelbard, HA | 1 |
| Gallitano, AL | 1 |
| Marsh, E | 1 |
| Steinpreis, RE | 2 |
| Salamone, JD | 1 |
| Dobie, DJ | 3 |
| Merchant, KM | 3 |
| Hamblin, MW | 1 |
| Vatassery, GT | 1 |
| Dysken, MW | 1 |
| Dorsa, DM | 3 |
| Johnson, SK | 1 |
| Fisher, H | 1 |
| Wagner, GC | 1 |
| Levin, ED | 1 |
| Torry, D | 1 |
| Matsumoto, RR | 1 |
| Bowen, WD | 1 |
| Walker, JM | 1 |
| Patrick, SL | 1 |
| Zambon, AC | 1 |
| Vo, VN | 1 |
| Truong, DD | 1 |
| De Costa, BR | 1 |
| Rice, KC | 1 |
| Lau, SM | 2 |
| Tang, F | 2 |
| Efange, SM | 1 |
| Langason, RB | 1 |
| Khare, AB | 1 |
| Schneider, JS | 1 |
| Wong, DF | 1 |
| Young, D | 1 |
| Wilson, PD | 1 |
| Meltzer, CC | 1 |
| Gjedde, A | 1 |
| Parret, F | 1 |
| Summ, RM | 1 |
| Panos, JJ | 1 |
| Lipska, BK | 1 |
| Weinberger, DR | 1 |
| Suzuki, A | 1 |
| Otani, K | 1 |
| Mihara, K | 1 |
| Yasui, N | 1 |
| Kondo, T | 1 |
| Tokinaga, N | 1 |
| Furukori, H | 1 |
| Kaneko, S | 1 |
| Inoue, Y | 1 |
| Hayashi, K | 1 |
| Speiser, Z | 1 |
| Levy, R | 1 |
| Cohen, S | 1 |
| Poeggeler, B | 1 |
| Rassoulpour, A | 1 |
| Guidetti, P | 1 |
| Wu, HQ | 1 |
| Schwarcz, R | 1 |
| Garver, DL | 1 |
| Nair, TR | 1 |
| Christensen, JD | 1 |
| Holcomb, J | 1 |
| Ramberg, J | 1 |
| Kingsbury, S | 1 |
| Hildebrandt, K | 1 |
| Teuchert-Noodt, G | 1 |
| Dawirs, RR | 1 |
| Beuzen, JN | 1 |
| Taylor, N | 1 |
| Wesnes, K | 1 |
| Wood, A | 1 |
| Wallace, DR | 1 |
| Mactutus, CF | 1 |
| Booze, RM | 1 |
| Lu, CC | 1 |
| Tsai, SC | 1 |
| Chien, EJ | 1 |
| Tsai, CL | 1 |
| Wang, PS | 1 |
| Kinkead, B | 1 |
| Owens, MJ | 1 |
| Nemeroff, CB | 1 |
| Yao, JK | 1 |
| Reddy, R | 1 |
| van Kammen, DP | 1 |
| Andorn, AC | 1 |
| Pappolla, MA | 1 |
| Baier, PC | 1 |
| Winkelmann, J | 1 |
| Höhne, A | 1 |
| Lancel, M | 1 |
| Trenkwalder, C | 1 |
| Hudick, JP | 1 |
| Wajda, IJ | 1 |
| Lajtha, A | 1 |
| Govoni, S | 1 |
| Cheronis, JC | 1 |
| Erinoff, L | 1 |
| Heller, A | 1 |
| Hoffmann, PC | 1 |
| Berger, RE | 1 |
| Engel, BT | 1 |
| Roth, GS | 1 |
| McLennan, IS | 1 |
| Lees, GJ | 1 |
| Gluckman, PD | 1 |
| Marti-Henneberg, C | 1 |
| Thomsett, MJ | 1 |
| Kaplan, SL | 1 |
| Rudolph, AM | 1 |
| Grumbach, MM | 1 |
| Baez, LA | 1 |
| Burt, DK | 1 |
| Granneman, J | 1 |
| Shanklin, C | 1 |
| Beasley, BA | 1 |
| Ford, DH | 1 |
| Frussa-Filho, R | 1 |
| Otoboni, JR | 1 |
| Uema, FT | 1 |
| Palermo-Neto, J | 1 |
| Calabresi, P | 1 |
| De Murtas, M | 1 |
| Mercuri, NB | 1 |
| Bernardi, G | 1 |
| Saija, A | 1 |
| Princi, P | 1 |
| Imperatore, C | 1 |
| De Pasquale, R | 1 |
| Costa, G | 1 |
| Creese, I | 2 |
| Sibley, DR | 1 |
| Xu, SX | 1 |
| Raskind, MA | 1 |
| Jahromi, SS | 1 |
| Niesen, C | 1 |
| Carlen, PL | 1 |
| Hoskins, B | 1 |
| Peeler, DF | 1 |
| Lawson, K | 1 |
| Barnes, AM | 1 |
| Ho, IK | 1 |
| Trent, F | 1 |
| Nakamura, S | 1 |
| Tepper, JM | 1 |
| Drucker-Colín, R | 1 |
| García-Hernández, F | 1 |
| Neal, BS | 1 |
| Joyce, JN | 1 |
| Sylvester, PW | 1 |
| Briski, KP | 1 |
| de la Cruz, F | 1 |
| Russek, M | 1 |
| Junquera, J | 1 |
| Chapman, CD | 1 |
| Howard, SG | 1 |
| Becú-Villalobos, D | 1 |
| Lacau-Mengido, IM | 1 |
| Libertun, C | 1 |
| Atterwill, CK | 1 |
| Brown, CG | 1 |
| Conybeare, G | 1 |
| Holland, CW | 1 |
| Jones, CA | 1 |
| Agnati, LF | 1 |
| Fuxe, K | 1 |
| Giardino, L | 1 |
| Calza, L | 1 |
| Zoli, M | 1 |
| Battistini, N | 1 |
| Benfenati, F | 1 |
| Vanderhaeghen, JJ | 1 |
| Guidolin, D | 1 |
| Ruggeri, M | 1 |
| Zisook, S | 1 |
| Braff, DL | 1 |
| Fine, MI | 1 |
| Masserano, JM | 1 |
| Weiner, N | 1 |
| Wambebe, C | 1 |
| Dalton, TK | 1 |
| Hunt, WA | 1 |
| Norman, AB | 1 |
| Battaglia, G | 1 |
| Popova, J | 1 |
| Kennes, D | 1 |
| Odberg, FO | 1 |
| Bouquet, Y | 1 |
| De Rycke, PH | 1 |
| Burchill, SA | 1 |
| Thody, AJ | 1 |
| Feldon, J | 1 |
| Erenberg, G | 1 |
| Cruse, RP | 1 |
| Rothner, AD | 1 |
| Demarest, KT | 2 |
| Moore, KE | 2 |
| Riegle, GD | 2 |
| Westerink, BH | 1 |
| Koolstra, W | 1 |
| Scalzo, FM | 1 |
| Spear, LP | 1 |
| Aoba, A | 1 |
| Kakita, Y | 1 |
| Yamaguchi, N | 1 |
| Shido, M | 1 |
| Tsuneizumi, T | 1 |
| Shibata, M | 1 |
| Kitani, K | 1 |
| Hasegawa, K | 1 |
| Pizzolato, G | 1 |
| Soncrant, TT | 1 |
| Holloway, HW | 1 |
| Gemperle, M | 1 |
| de Groot, MH | 1 |
| Sirtori, C | 1 |
| Smith, GR | 1 |
| Taylor, CW | 1 |
| Walker, JB | 1 |
| Walker, JP | 1 |
| Vertua, R | 1 |
| Furlani, A | 1 |
| Smran, A | 1 |
| Abdullah, M | 1 |
| Ahmad, NA | 1 |
| Alrahlah, A | 1 |
| Al-Maflehi, N | 1 |
| Samran, A | 1 |
| Suskov, II | 1 |
| Sazonova, LA | 1 |
5 reviews available for haloperidol and Aging
| Article | Year |
|---|---|
[Effect of factors on plasma haloperidol concentration/dose ratio].
Topics: Aging; Antipsychotic Agents; Body Weight; Cytochrome P-450 CYP2D6; Dose-Response Relationship, Drug; | 2003 |
Neurotransmitter receptors in the central nervous system and aging: pharmacological aspect (review).
Topics: Adenylyl Cyclases; Aging; Animals; Brain; Desipramine; Dopamine; Dopamine Antagonists; Female; Fluph | 1984 |
Neuroleptic concentrations and clinical response.
Topics: Aging; Antipsychotic Agents; Chlorpromazine; Chronic Disease; Drug Interactions; Fluphenazine; Halop | 1984 |
Aging and the extrapyramidal system.
Topics: Aged; Aging; Basal Ganglia Diseases; Chlorpromazine; Chorea; Dopamine; Frontal Lobe; Gait; Haloperid | 1976 |
Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs.
Topics: Aging; Animals; Antipsychotic Agents; Brain; Caudate Nucleus; Cyclic AMP Response Element-Binding Pr | 1992 |
3 trials available for haloperidol and Aging
| Article | Year |
|---|---|
Effects of various factors including the CYP2D6 genotype and coadministration of flunitrazepam on the steady-state plasma concentrations of bromperidol and its reduced metabolite.
Topics: Adolescent; Adult; Aged; Aging; Anti-Anxiety Agents; Antipsychotic Agents; Biotransformation; Cytoch | 1998 |
Atrophic and static (neurodevelopmental) schizophrenic psychoses: premorbid functioning, symptoms and neuroleptic response.
Topics: Adult; Aging; Alcohol Drinking; Algorithms; Antipsychotic Agents; Atrophy; Brain; Cerebral Ventricle | 1999 |
A comparison of the effects of olanzapine, haloperidol and placebo on cognitive and psychomotor functions in healthy elderly volunteers.
Topics: Aged; Aged, 80 and over; Aging; Antipsychotic Agents; Attention; Benzodiazepines; Cognition; Cross-O | 1999 |
119 other studies available for haloperidol and Aging
| Article | Year |
|---|---|
Interhemispheric differences of pyramidal cells in the primary motor cortices of schizophrenia patients investigated postmortem.
Topics: Aged; Aged, 80 and over; Aging; Animals; Antipsychotic Agents; Autopsy; Datasets as Topic; Disease M | 2023 |
The effects of aging and dopaminergic inhibition on large scale maze learning in rhesus monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Intravenous; Aging; Anim | 2021 |
Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice.
Topics: Acetylation; Aging; Animals; Benzamides; Corpus Striatum; Dopamine Antagonists; Haloperidol; Histone | 2017 |
Postnatal manganese exposure does not alter dopamine autoreceptor sensitivity in adult and adolescent male rats.
Topics: Aging; Animals; Animals, Newborn; Apomorphine; Autoreceptors; Behavior, Animal; Corpus Striatum; Dop | 2013 |
Haloperidol overdosing in the treatment of agitated hospitalized older people with delirium: a retrospective chart review from a community teaching hospital.
Topics: Aged; Aged, 80 and over; Aging; Anti-Anxiety Agents; Delirium; Dopamine Antagonists; Dose-Response R | 2013 |
Chronic high fat diet consumption impairs sensorimotor gating in mice.
Topics: Acoustic Stimulation; Aging; Animals; Diet, High-Fat; Dietary Fats; Dopamine Antagonists; Dopaminerg | 2013 |
HDAC inhibitors restore the capacity of aged mice to respond to haloperidol through modulation of histone acetylation.
Topics: Acetylation; Aging; Animals; Avoidance Learning; Benzamides; Conditioning, Psychological; Dopamine A | 2014 |
Differential effects of intermittent versus continuous haloperidol treatment throughout adolescence on haloperidol sensitization and social behavior in adulthood.
Topics: Aging; Animals; Antipsychotic Agents; Avoidance Learning; Drug Delivery Systems; Haloperidol; Male; | 2014 |
Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats.
Topics: Aging; Animals; Antipsychotic Agents; Cells, Cultured; CHO Cells; Clozapine; Cricetinae; Cricetulus; | 2008 |
Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat.
Topics: Aging; Amphetamine; Animals; Animals, Newborn; Antipsychotic Agents; Benzamides; Central Nervous Sys | 2009 |
To breed or not to breed? Empirical evaluation of drug effects in adolescent rats.
Topics: Aging; Animals; Antipsychotic Agents; Breeding; Catalepsy; Clozapine; Dose-Response Relationship, Dr | 2009 |
Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment.
Topics: Aging; Animals; Anxiety; Apomorphine; Behavior, Animal; Benzoxazines; Brain; Cannabinoids; Dopamine | 2009 |
The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats.
Topics: Aging; Analysis of Variance; Animals; Antipsychotic Agents; Clozapine; Disease Models, Animal; Dopam | 2010 |
Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.
Topics: Aging; Animals; Animals, Newborn; Antipsychotic Agents; Aripiprazole; Autoreceptors; Brain Chemistry | 2010 |
Histamine- and haloperidol-induced catalepsy in aged mice: differential responsiveness to L-DOPA.
Topics: Aging; Animals; Antiparkinson Agents; Catalepsy; Disease Models, Animal; Dopamine; Dose-Response Rel | 2012 |
Somatostatin antagonist potentiates haloperidol-induced catalepsy in the aged rat.
Topics: Aging; Animals; Antipsychotic Agents; Catalepsy; Drug Synergism; Haloperidol; Male; Rats; Rats, Wist | 2012 |
Somatostatin antagonist induces catalepsy in the aged rat.
Topics: Age Factors; Aging; Animals; Brain; Catalepsy; Dose-Response Relationship, Drug; Haloperidol; Inject | 2013 |
Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia.
Topics: Aging; Amphetamine; Animals; Central Nervous System Stimulants; Clozapine; Corpus Striatum; Disease | 2003 |
Role of aging and striatal nitric oxide synthase activity in an animal model of tardive dyskinesia.
Topics: Aging; Analysis of Variance; Animals; Behavior, Animal; Comorbidity; Corpus Striatum; Disease Models | 2003 |
Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats.
Topics: Aging; Analysis of Variance; Animals; Behavior, Animal; Cell Count; Disease Models, Animal; Drug Adm | 2003 |
Aging process of epithelial cells of the rat prostate lateral lobe in experimental hyperprolactinemia induced by haloperidol.
Topics: Aging; Animals; Disease Models, Animal; Epithelial Cells; Haloperidol; Hyperprolactinemia; Male; Pro | 2004 |
Antipsychotic-induced suppression of locomotion in juvenile, adolescent and adult rats.
Topics: Age Factors; Aging; Animals; Antipsychotic Agents; Behavior, Animal; Clozapine; Dose-Response Relati | 2008 |
Enkephalin receptor changes in rat brain during aging.
Topics: Aging; Animals; Cerebral Cortex; Corpus Striatum; Haloperidol; Hypothalamus; Levodopa; Male; Rats; R | 1984 |
Dopamine receptor alterations with aging in mouse and rat corpus striatum.
Topics: Aging; Animals; Corpus Striatum; Dopamine; Haloperidol; In Vitro Techniques; Kinetics; Male; Mice; R | 1981 |
Characterization of the rat mutant dystonic (dt): a new animal model of dystonia musculorum deformans.
Topics: Aging; Animals; Apomorphine; Brain Chemistry; Disease Models, Animal; Dopamine; Dystonia Musculorum | 1984 |
Decreased catalepsy response to haloperidol in the genetically dystonic (dt) rat.
Topics: 4-Butyrolactone; Aging; Animals; Brain; Catalepsy; Corpus Striatum; Dopamine; Dystonia; Golgi Appara | 1984 |
Psychomotor performance in the senescent rodent: reduction of deficits via striatal dopamine receptor up-regulation.
Topics: Aging; Animals; Apomorphine; Corpus Striatum; Haloperidol; Humans; Motor Skills; Rats; Rats, Inbred | 1983 |
Effects of pre- and postnatal haloperidol administrations to pregnant and nursing rats on brain catecholamine levels in their offspring.
Topics: Aging; Animals; Animals, Suckling; Brain; Brain Chemistry; Catecholamines; Dopamine; Female; Haloper | 1984 |
Haloperidol differentially potentiates tonic immobility, the dorsal immobility response, and catalepsy in the developing rat.
Topics: Aging; Animals; Brain; Female; Haloperidol; Male; Motor Activity; Posture; Rats; Rats, Inbred Strain | 1984 |
Tourette syndrome: history and present status.
Topics: Aging; Clonidine; Demography; Ethnicity; Forecasting; Haloperidol; History, 15th Century; History, 1 | 1982 |
Developmental patterns of the hypothalamic-pituitary axis in the euthyroid and hypothyroid male rat.
Topics: Aging; Animals; Animals, Newborn; Gonadotropin-Releasing Hormone; Haloperidol; Hypothalamo-Hypophyse | 1980 |
Effects of maturation and aging on behavioral responses to haloperidol in the rat.
Topics: Aging; Animals; Behavior, Animal; Blepharoptosis; Dose-Response Relationship, Drug; Haloperidol; Mal | 1981 |
Blood levels of haloperidol in schizophrenic patients.
Topics: Adolescent; Adult; Aging; Drug Interactions; Erythrocytes; Female; Half-Life; Haloperidol; Humans; M | 1983 |
Age effects on haloperidol pharmacokinetics in male, Fischer-344 rats.
Topics: Aging; Animals; Brain; Haloperidol; Kinetics; Male; Rats; Rats, Inbred F344 | 1982 |
Postnatal development of noradrenaline and 3-methoxy-4-hydroxyphenylethyleneglycol sulphate levels in rat brain regions.
Topics: Aging; Animals; Animals, Newborn; Brain; Glycols; Haloperidol; Male; Methoxyhydroxyphenylglycol; Nor | 1982 |
[Plasma level monitoring of psychotropic drugs in children. I-Haloperidol (author's transl)].
Topics: Adolescent; Adult; Aging; Child; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male | 1982 |
Study on some compensatory responses of dopaminergic system in aging rats.
Topics: Aging; Animals; Apomorphine; Butyrophenones; Corpus Striatum; Feedback; Haloperidol; Homovanillic Ac | 1982 |
Apomorphine-induced stereotypy in mature and senescent rats following cessation of chronic haloperidol treatment.
Topics: Aging; Animals; Apomorphine; Haloperidol; Humans; Male; Rats; Rats, Inbred Strains; Stereotyped Beha | 1980 |
Aging and the regulation of striatal dopaminergic mechanisms in mice.
Topics: Aging; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Haloperidol; Humans; Male; Mice; Mice, | 1981 |
Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro.
Topics: Adult; Aged; Aging; Drug Interactions; Female; Haloperidol; Humans; Male; Middle Aged; Oleic Acids; | 1981 |
Aging and haloperidol-induced dopamine turnover in the nigro-striatal pathway of C57BL/6J mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Haloperidol; Male; Methyl | 1981 |
Age-related electrophysiological changes in rat cerebellum.
Topics: Aging; Amphetamine; Animals; Cerebellum; Fluphenazine; gamma-Aminobutyric Acid; Haloperidol; Locus C | 1980 |
Aging process affects a single class of dopamine receptors.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Aging; Animals; Corpus Striatum; Haloperidol; Hum | 1980 |
The role of hyperthermia in amphetamine's interactions with NMDA receptors, nitric oxide, and age to produce neurotoxicity.
Topics: Aging; Amphetamine; Animals; Arginine; Brain; Dizocilpine Maleate; Fever; Glutamic Acid; Haloperidol | 1995 |
Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Amitriptyline; Amygdala; Analysis of Variance; Animals; Brain | 1993 |
The D2 autoreceptor agonists SND 919 and PD 128483 decrease stereotypy in developing rats.
Topics: Aging; Aminoquinolines; Animals; Benzothiazoles; Dopamine Agents; Dose-Response Relationship, Drug; | 1994 |
Adaptive changes in rat striatal preproenkephalin expression and dopamine-opioid interactions upon chronic haloperidol treatment during different developmental stages.
Topics: Aging; Animals; Corpus Striatum; Dopamine; Embryonic and Fetal Development; Enkephalin, Ala(2)-MePhe | 1994 |
Differential regulation of glutamate decarboxylase and preproenkephalin mRNA levels in the rat striatum.
Topics: Aging; Animals; Animals, Newborn; Autoradiography; Dopamine; Enkephalins; Female; Glutamate Decarbox | 1994 |
Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; Dose-Response Relationshi | 1993 |
Effects of acute haloperidol and reserpine administration on vacuous jaw movements in three different age groups of rats.
Topics: Aging; Animals; Haloperidol; Jaw; Male; Mastication; Motor Activity; Rats; Rats, Sprague-Dawley; Res | 1993 |
Blunting of the neurotensin mRNA response to haloperidol in the striatum of aging rats: possible relationship to decline in dopamine D2 receptor expression.
Topics: Aging; Analysis of Variance; Animals; Autoradiography; Corpus Striatum; Gene Expression; Haloperidol | 1993 |
Partial 6-hydroxydopamine-induced lesions and haloperidol-induced catalepsy.
Topics: Aging; Animals; Apomorphine; Brain Chemistry; Catalepsy; Corpus Striatum; Dose-Response Relationship | 1993 |
Acute and chronic nicotine effects on working memory in aged rats.
Topics: Age Factors; Aging; Animals; Dose-Response Relationship, Drug; Haloperidol; Male; Maze Learning; Mec | 1996 |
Dissociation of the motor effects of (+)-pentazocine from binding to sigma 1 sites.
Topics: Aging; Animals; Central Nervous System Depressants; Dystonia; Haloperidol; Head Movements; In Vitro | 1996 |
The effect of haloperidol on met-enkephalin, beta-endorphin, cholecystokinin and substance P in the pituitary, the hypothalamus and the striatum of rats during aging.
Topics: Aging; Animals; beta-Endorphin; Cholecystokinin; Corpus Striatum; Enkephalin, Methionine; Haloperido | 1995 |
Age-related diminution of dopamine antagonist-stimulated vesamicol receptor binding.
Topics: Aging; Animals; Brain; Dopamine Antagonists; Haloperidol; Iodine Radioisotopes; Iodobenzenes; Male; | 1996 |
Preservation of autoreceptor-mediated increases in dopamine synthesis in aged mice with experimentally-induced parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Aromat | 1997 |
Quantification of neuroreceptors in the living human brain: III. D2-like dopamine receptors: theory, validation, and changes during normal aging.
Topics: Aging; Algorithms; Animals; Brain; Brain Chemistry; Computer Simulation; Corpus Striatum; Dopamine A | 1997 |
Effects of clozapine and haloperidol on baseline levels of vacuous jaw movements in aged rats.
Topics: Aging; Animals; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Haloperidol; Mast | 1997 |
Prefrontal cortical and hippocampal modulation of dopamine-mediated effects.
Topics: Aging; Amphetamine; Animals; Animals, Newborn; Apomorphine; Disease Models, Animal; Dopamine; Halope | 1998 |
Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disorders.
Topics: Aging; alpha-Methyltyrosine; Animals; Avoidance Learning; Catalepsy; Cognition; Cognition Disorders; | 1998 |
The effect of aging on the response of striatal preproenkephalin and preprotachykinin mRNA contents to chronic haloperidol treatment in rats: measurement by solution-hybridization RNase protection assay.
Topics: Aging; Animals; Corpus Striatum; Enkephalins; Haloperidol; Male; Protein Precursors; Rats; Rats, Spr | 1998 |
Dopaminergic control of kynurenate levels and N-methyl-D-aspartate toxicity in the developing rat striatum.
Topics: Aging; Animals; Animals, Newborn; Corpus Striatum; Dextroamphetamine; Dopamine; Dopamine Agents; Dop | 1998 |
A single neonatal dose of methamphetamine suppresses dentate granule cell proliferation in adult gerbils which is restored to control values by acute doses of haloperidol.
Topics: Aging; Animals; Animals, Newborn; Bromodeoxyuridine; Cell Division; Dentate Gyrus; Gerbillinae; Halo | 1999 |
Sigma binding sites identified by [(3)H] DTG are elevated in aged Fischer-344 x Brown Norway (F1) rats.
Topics: Aging; Animals; Anticonvulsants; Binding Sites; Corpus Striatum; Guanidines; Haloperidol; Male; Racl | 2000 |
Age-related differences in the secretion of calcitonin in male rats.
Topics: Aging; Animals; Calcitonin; Calcium; Calcium Chloride; Dopamine Antagonists; Haloperidol; In Vitro T | 2000 |
The effects of acute antipsychotic drug administration on the neurotensin system of the developing rat brain.
Topics: Aging; Animals; Animals, Newborn; Antipsychotic Agents; Brain; Caudate Nucleus; Female; Haloperidol; | 2000 |
Abnormal age-related changes of plasma antioxidant proteins in schizophrenia.
Topics: Adolescent; Adult; Age Factors; Aging; Albumins; Antipsychotic Agents; Anxiety; Bilirubin; Depressio | 2000 |
Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer's disease brain.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adult; Aged; Aging; Alzheimer Disease; Autopsy; Brain; Catec | 2001 |
Assessment of spontaneously occurring periodic limb movements in sleep in the rat.
Topics: Aging; Animals; Anti-Dyskinesia Agents; Haloperidol; Hindlimb; Male; Movement; Periodicity; Rats; Ra | 2002 |
The amphetamine-induced inhibition of dopamine biosynthesis in rat striatum.
Topics: Aging; Animals; Animals, Newborn; Corpus Striatum; Depression, Chemical; Dextroamphetamine; Dopamine | 1976 |
[3H]Haloperidol and [3H]spiroperidol binding in rat striatum during ageing.
Topics: Adenylyl Cyclases; Aging; Animals; Binding Sites; Butyrophenones; Corpus Striatum; Dopamine; Haloper | 1978 |
Pharmacological analysis of the functional ontogeny of the nigrostriatal dopaminergic neurons.
Topics: Aging; Animals; Animals, Newborn; Axons; Corpus Striatum; Dominance, Cerebral; Dopamine; Haloperidol | 1979 |
Age-related changes in the nigrostriatum: a behavioral and biochemical analysis.
Topics: Aging; Amphetamine; Animals; Apomorphine; Female; Haloperidol; Male; Rats; Rats, Inbred Strains; Rec | 1978 |
The development of tryptophan hydroxylase in the chicken brain: effects of p-chloroamphetamine and antagonists of serotonin, noradrenaline and dopamine.
Topics: Aging; Amphetamines; Animals; Brain; Chick Embryo; Chickens; Dopamine Antagonists; Haloperidol; Nore | 1979 |
Hormone ontogeny in the ovine fetus. VI. Dopaminergic regulation of prolactin secretion.
Topics: Aging; Animals; Animals, Newborn; Apomorphine; Bromocriptine; Dopamine; Female; Fetus; Gestational A | 1979 |
Haloperidol plasma level monitoring in pediatric patients.
Topics: Adolescent; Adult; Aging; Child; Female; Haloperidol; Humans; Male; Movement Disorders; Psychotic Di | 1979 |
Dopaminergic antagonism and catalepsy in the developing rat.
Topics: Aging; Animals; Catalepsy; Dopamine; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Rats; | 1979 |
Effects of age and isolation on the evolution of catalepsy during chronic haloperidol treatment.
Topics: Aging; Animals; Catalepsy; Drug Tolerance; Haloperidol; Housing, Animal; Male; Rats; Social Isolatio | 1992 |
Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission.
Topics: Aging; Animals; Antipsychotic Agents; Corpus Striatum; Ergolines; Glutamine; Haloperidol; Parasympat | 1992 |
Ageing influences haloperidol-induced changes in the permeability of the blood-brain barrier in the rat.
Topics: Aging; Aminoisobutyric Acids; Animals; Blood-Brain Barrier; Cerebrovascular Circulation; Dopamine; H | 1992 |
Expression of rat striatal D1 and D2 dopamine receptor mRNAs: ontogenetic and pharmacological studies.
Topics: Aging; Animals; Animals, Newborn; Base Sequence; Benzazepines; Corpus Striatum; Haloperidol; Male; M | 1992 |
Neurotensin mRNA expression in response to haloperidol is decreased in the dorsolateral striatum of aged rats.
Topics: Aging; Animals; Corpus Striatum; Gene Expression; Haloperidol; Male; Neurotensin; Peptide Fragments; | 1992 |
Amphetamine actions on pre- and postpubertal rat hippocampal dentate granule neurons.
Topics: Aging; Animals; Atenolol; Calcium Channels; Cocaine; Dextroamphetamine; Evoked Potentials; Haloperid | 1991 |
Effects of haloperidol on motor and cognitive functioning in aged mice.
Topics: Aging; Animals; Cognition; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Mice, Inbred S | 1991 |
Amphetamine exerts anomalous effects on dopaminergic neurons in neonatal rats in vivo.
Topics: Aging; Animals; Animals, Newborn; Apomorphine; Corpus Striatum; Dextroamphetamine; Dopamine; Electri | 1991 |
A new motor test sensitive to aging and dopaminergic function.
Topics: Aging; Animals; Body Weight; Dextroamphetamine; Dopamine; Haloperidol; Levodopa; Male; Motor Activit | 1991 |
Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aging; Analysis of Variance; Animals; An | 1991 |
Diminished bioactivity of circulating prolactin despite increased immunoreactive hormone release in old versus young male rats.
Topics: Aging; Animals; Biological Assay; Bromocriptine; Cell Division; Haloperidol; Lymphoma; Male; Morphin | 1990 |
Ontogeny of the endorphinergic and dopaminergic modulation on the immobility reflex elicited by clamping in rats.
Topics: Aging; Animals; Animals, Newborn; Apomorphine; Behavior, Animal; Dopamine; Dose-Response Relationshi | 1990 |
Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dialysis; Dopamine; Female; Haloper | 1990 |
Developmental changes in FSH secretion induced by 5-hydroxytryptophan, naloxone and haloperidol in male and female rats.
Topics: 5-Hydroxytryptophan; Aging; Animals; Female; Follicle Stimulating Hormone; Haloperidol; Male; Naloxo | 1989 |
Relation between dopaminergic control of pituitary lactotroph function and deceleration of age-related changes in serum prolactin of diet-restricted rats.
Topics: Aging; Animals; Bromocriptine; Catalepsy; Diet; Dopamine; Female; Haloperidol; Male; Pituitary Gland | 1989 |
Evidence for cholecystokinin-dopamine receptor interactions in the central nervous system of the adult and old rat. Studies on their functional meaning.
Topics: Aging; Animals; Apomorphine; Brain; Cholecystokinin; Haloperidol; Male; Neurons; Nucleus Accumbens; | 1985 |
Delirium: recognition and management in the older patient.
Topics: Aged; Aging; Anti-Anxiety Agents; Benzodiazepines; Delirium; Diagnosis, Differential; Drug-Related S | 1986 |
The effects of reserpine and haloperidol on tyrosine hydroxylase activity in the brains of aged rats.
Topics: Aging; Animals; Brain; Brain Mapping; Haloperidol; Male; Pterins; Rats; Reserpine; Tyrosine 3-Monoox | 1986 |
Influence of (-)-sulpiride and YM-09151-2 on stereotyped behavior in chicks and catalepsy in rats.
Topics: Aging; Animals; Antipsychotic Agents; Benzamides; Catalepsy; Chickens; Dextroamphetamine; Fenclonine | 1987 |
Decreasing sensitivity to neuroleptic agents in developing rats; evidence for a pharmacodynamic factor.
Topics: Administration, Oral; Aging; Animals; Antipsychotic Agents; Generalization, Psychological; Haloperid | 1988 |
Age-related decrements in the muscarinic enhancement of K+-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence.
Topics: Aging; Animals; Bethanechol; Bethanechol Compounds; Carbachol; Cholinergic Fibers; Corpus Striatum; | 1988 |
Differential recovery rates of rat D2 dopamine receptors as a function of aging and chronic reserpine treatment following irreversible modification: a key to receptor regulatory mechanisms.
Topics: Aging; Animals; Apomorphine; Corpus Striatum; Guanylyl Imidodiphosphate; Haloperidol; In Vitro Techn | 1987 |
Changes in the 5-HT-binding sites in the cerebral cortex, striatum and hypothalamus of rats during ageing and under the effect of dopaminergic agents.
Topics: Aging; Animals; Binding Sites; Cerebral Cortex; Corpus Striatum; Haloperidol; Hypothalamus; Levodopa | 1987 |
Changes in naloxone and haloperidol effects during the development of captivity-induced jumping stereotypy in bank voles.
Topics: Aging; Animals; Arvicolinae; Haloperidol; Naloxone; Stereotyped Behavior | 1988 |
Dopaminergic inhibition of tyrosinase activity in hair follicular melanocytes of the mouse.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aging; Animals; Benzazepines; Bromocript | 1986 |
Long-term attentional deficit in nonhandled males: possible involvement of the dopaminergic system.
Topics: Aging; Animals; Attention; Dextroamphetamine; Female; Haloperidol; Handling, Psychological; Male; Ra | 1988 |
The natural history of Tourette syndrome: a follow-up study.
Topics: Adaptation, Psychological; Adolescent; Adolescent Behavior; Adult; Aging; Clonidine; Fluphenazine; F | 1987 |
Responsiveness of tuberoinfundibular dopamine neurons in the aged female rat to the stimulatory actions of prolactin.
Topics: Aging; Animals; Dopamine; Feedback; Female; Haloperidol; Homeostasis; Hypothalamus; Median Eminence; | 1987 |
Circadian variation of catecholamine excretion in rats: correlation with locomotor activity and effects of drugs.
Topics: Aging; Animals; Catecholamines; Circadian Rhythm; Dopamine; Epinephrine; Haloperidol; Male; Motor Ac | 1986 |
Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats.
Topics: 4-Butyrolactone; Aging; Animals; Body Weight; Corpus Striatum; Dopamine; Female; Haloperidol; Limbic | 1985 |
Adenohypophysial dopamine content and prolactin secretion in the aged male and female rat.
Topics: Aging; Animals; Biomechanical Phenomena; Brain; Bromocriptine; Catechol O-Methyltransferase; Dopamin | 1985 |
Absence of age effect on plasma haloperidol neuroleptic levels in psychiatric patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aging; Female; Haloperidol; Humans; Male; Middle Aged | 1985 |
Reduced metabolic response of the aged rat brain to haloperidol.
Topics: Aging; Animals; Autoradiography; Brain; Catalepsy; Deoxyglucose; Glucose; Haloperidol; Male; Rats; R | 1985 |
[Neuroleptoanalgesia].
Topics: Aged; Aging; Animals; Cardiac Surgical Procedures; Cardiovascular System; Catecholamines; Central Ne | 1970 |
The clinical use of psychotherapeutic drugs in the elderly.
Topics: Aged; Aging; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety; Benzodiazepi | 1974 |
[Collecting of the news].
Topics: Aging; Air Pollution; Haloperidol; Health Education; Humans; Italy; Myocardial Infarction; Neoplasms | 1974 |
Management of the psychogeriatric patient.
Topics: Aged; Aging; Female; Haloperidol; Humans; Male; Mental Disorders | 1973 |
Properties of adenylate cyclase from senescent rat brain.
Topics: Adenylyl Cyclases; Aging; Animals; Brain; Caudate Nucleus; Cell-Free System; Cerebellum; Cerebral Co | 1973 |
Distribution of radioactivity in the tissues of young and adult rats after administration of tritiated haloperidol.
Topics: Aging; Animals; Brain; Haloperidol; Injections, Intraperitoneal; Intestinal Mucosa; Kidney; Liver; L | 1968 |
Influence of long -term thermal cycling and masticatory loading simulation on bond strength of roots filled with epoxy resin and calcium silicate based sealers.
Topics: Aging; Analysis of Variance; Calcium Compounds; Epoxy Resins; Humans | 2023 |
[Human cytogenetic affects in relation to sex, age and the duration of contract with a chemical mutagen].
Topics: Adult; Aging; Chromosome Aberrations; Environmental Exposure; Epoxy Resins; Female; Humans; Lymphocy | 1983 |